AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly...

Molecular Cancer Therapeutics 2015 / 11 Vol. 14; Iss. 11

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

Guichard, S. M., Curwen, J., Bihani, T., D'Cruz, C. M., Yates, J. W. T., Grondine, M., Howard, Z., Davies, B. R., Bigley, G., Klinowska, T., Pike, K. G., Pass, M., Chresta, C. M., Polanska, U. M., McE
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-15-0365
Date:
November, 2015
File:
PDF, 1.52 MB
english, 2015
Conversion to is in progress
Conversion to is failed